CSL Shares Hold A$200 Break: 52-Week High Brings Overbought Signal
CSL shares (ASX: CSL) hit a new 52-week high at A$202.85 to start November, extending a stunning 123% recovery from its lows to hold the A$200 break. It has been a huge year of two halves for the stock, with the latest leg higher pushing the RSI towards the most overbought on the ASX. The…
Northern Star Resources Shares Move Red YTD, As Gold Prices Pull Back
Northern Star Resources shares (ASX: NST) turned negative YTD following a 4.75% sell-off on Monday, as a broader commodity pullback, and softening gold prices weighed heavily on the stock. The move is more than a one-day wobble, but comes against a backdrop of operational transition, activist-driven management change, and a rejected takeover offer that together…
DroneShield Shares Make New Low, As Pressure Mounts
DroneShield shares (ASX: DRO) began November with a new 52-week low, extending what has been a difficult year for holders. The stock has fallen back 60% since the turn of 2026, as markets continue to punish the surprise net loss, ongoing regulatory questions, and the notoriously unpredictable rhythm of defence procurement cycles. The DroneShield share…
AMP Shares Pull Back From Resistance: What Happened?
AMP shares (ASX: AMP) were the worst performer on the ASX 200 on Monday, pulling back 7.48% after once again failing to hold a breakout above the A$2.50 resistance level. The AMP share price began the week above A$2.50, before sellers took control and drove the stock as low as A$2.22 within the first couple…
ResMed Shares Dip On Earnings, Bullish Analyst Shifts Neutral
ResMed shares (ASX:RMD) fell back 5.77% to start November, as markets reacted to Q1 results, and a broker downgrade that saw a previously bullish analyst shift neutral. The ResMed share price closed at A$33.46 on Monday, with Canaccord’s decision to downgrade the stock from Buy to Hold, cutting its price target from A$40.00 to A$35.61…
ASX Resources and Energy Stocks Gain New Analyst Coverage: The Calls
BMO Capital fired the starting gun on a comprehensive initiation of ASX resources stocks, assigning Outperform ratings to more than 40 ASX-listed mining, energy, and services companies. The move follows BMO’s acquisition of the Perth-based capital markets division of Euroz Hartleys Group, cementing the Canadian investment bank’s ambitions as a dominant global force in Australian…
ASX 200 Starts November Soft: Rate Hike Fears & Gold Pullback Weigh
The ASX 200 started the new month on the back foot, falling back 0.58% to 8,856.50, with the expected RBA rate hike, and a pullback in gold and commodity prices weighing on the index. ASX 200 Today Laggards The session’s losses were broad, but also concentrated in the index’s heaviest sectors. Consumer Staples bore the…
Westpac Shares Outperform on FY26 Results: Here’s Why
Westpac shares (ASX:WBC) closed 1.0% higher at A$37.19 to start the week, pushing the stock toward a technically significant level off the back of FY26 results. The 200-day moving average at A$37.34 has been tested once more, a level that has acted as a reliable resistance on rally attempts over the past several months. But…
4DMedical Shares Flip From Laggard to Leader on the ASX 200: Here’s Why
4DMedical shares (ASX: 4DX) started the new trading week in much stronger fashion, bouncing 6.56% to A$2.60, leading the ASX 200 the session following an index worst performance. The turnaround was supported by management’s response to a formal ASX price query, which pointed the finger at short sellers rather than any deterioration in the company’s…
Elevra Lithium Shares Shed 43.5% On Month, As Pressure Mounts
Elevra Lithium shares (ASX:ELV) fell 43.5% in October to A$3.19, with selling pressure continuing right into the month end, with a fresh 52wk low at A$3.13 intraday. There is no let up for ELV holders, even as the company sits on fresh cash from a completed asset sale, with lithium names hitting another wall. What…
